Skip to content
Computational Drug Development for Biologics - Home Page Banner

4th Annual Computational Drug Development for Biologics

Never has our understanding of biology and computation been evolving more rapidly. But what can these complex fields tell each other and how can they be integrated? For drug developers now is the time to harness this computing power to identify and to advance biologics candidates of superior affinity, stability and efficacy.

However, with the field in its infancy, there remains an ever-present need to address current capabilities amongst the scientific and operational challenges that exist when modelling complex biologics.

CDD for Biologics has been specifically designed to help biopharmaceutical companies define strategies to further adapt these tools, mitigate data availability issues and address computational-experimental challenges to add immediate value to their biologics pipelines.

Join a diverse faculty of experts from pharma, biotech, software developers and academia as we provide the platform to discuss what is needed to accelerate computational capability to the next level.

Hear What Our Attendees Say

“It’s a great conference in the sense that we take home not only new methods and models, but more importantly the design and thinking process behind them” – Yao Fan, Boehringer Ingelheim

“I’m impressed by how much I learnt by attending the conference. It’s a great opportunity to learn the key issues facing the industry and various strategies to address them. It was very rewarding” - Liwei Li, EMD Serono

Partners:

Chemical Computing Group
Schrodinger Company Logo

Attending Companies:

Biogen Company Logo
Genentech Company Logo
Sanofi Company Logo
EMD Serono Company Logo
Bristol-Myers Squibb Company Logo
Merck Company Logo
Kadmon Company Logo
Just Biotherapeutics Company Logo